Sanjay S. Subramanian

2022

In 2022, Sanjay S. Subramanian earned a total compensation of $1.2M as Senior Vice President and Chief Financial Officer at Inozyme Pharma.

Compensation breakdown

Bonus$105,000
Non-Equity Incentive Plan$189,200
Option Awards$522,141
Salary$430,000
Other$2,100
Total$1,248,441

Subramanian received $522.1K in option awards, accounting for 42% of the total pay in 2022.

Subramanian also received $105K in bonus, $189.2K in non-equity incentive plan, $430K in salary and $2.1K in other compensation.

Rankings

In 2022, Sanjay S. Subramanian's compensation ranked 2,597th out of 5,697 executives tracked by ExecPay. In other words, Subramanian earned more than 54.4% of executives.

ClassificationRankingPercentile
All
2,597
out of 5,697
54th
Division
Manufacturing
1,439
out of 3,099
54th
Major group
Chemicals And Allied Products
653
out of 1,406
54th
Industry group
Drugs
606
out of 1,307
54th
Industry
Pharmaceutical Preparations
434
out of 953
55th
Source: SEC filing on April 27, 2023.

Subramanian's colleagues

We found two more compensation records of executives who worked with Sanjay S. Subramanian at Inozyme Pharma in 2022.

2022

Axel Bolte

Inozyme Pharma

Chief Executive Officer

2022

Henric Bjarke

Inozyme Pharma

Chief Operating Officer

News

You may also like